Recent advances in the treatment of FLT3-mutated acute myeloid leukemia
Blood Research · 2026-12 · 61 (1)
DOI: 10.1007/s44313-026-00155-0 ↗Kurz gefasst
Leserbrief in der Zeitschrift Blood Research, online erschienen am 09.07.2026. Verfasst von Jeong Suk Koh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hemato-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, South Korea. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by t….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Hemato-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, South Korea.
- Division of Hemato-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, South Korea. petrosong@cnu.ac.kr.
Förderung
- This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by t…
Zitieren
APA
Koh, J. S., & Song, I. C. (2026). Recent advances in the treatment of FLT3-mutated acute myeloid leukemia. Blood Research, 61(1). https://doi.org/10.1007/s44313-026-00155-0
Vancouver
Koh JS, Song IC. Recent advances in the treatment of FLT3-mutated acute myeloid leukemia. Blood Research. 2026;61(1). doi:10.1007/s44313-026-00155-0
BibTeX
@article{Koh2026,
author = {Koh, Jeong Suk and Song, Ik-Chan},
title = {Recent advances in the treatment of FLT3-mutated acute myeloid leukemia},
journal = {Blood Research},
year = {2026},
volume = {61},
number = {1},
doi = {10.1007/s44313-026-00155-0}
}
EUVIMED